These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10785843)

  • 1. The role of costimulatory molecules as targets for new immunosuppressives in transplantation.
    Kishimoto K; Dong VM; Sayegh MH
    Curr Opin Urol; 2000 Mar; 10(2):57-62. PubMed ID: 10785843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blocking costimulatory signals to induce transplantation tolerance and prevent autoimmune disease.
    Khoury S; Sayegh MH; Turka LA
    Int Rev Immunol; 1999; 18(3):185-99. PubMed ID: 10614723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cell costimulatory pathways: promising novel targets for immunosuppression and tolerance induction.
    Sayegh MH; Turka LA
    J Am Soc Nephrol; 1995 Oct; 6(4):1143-50. PubMed ID: 8589280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coinhibitory T-cell signaling in islet allograft rejection and tolerance.
    Truong W; Hancock WW; Anderson CC; Merani S; Shapiro AM
    Cell Transplant; 2006; 15(2):105-19. PubMed ID: 16719045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New look at therapeutic strategies for blocking costimulatory signal in experimental and pre-clinical transplantation.
    Ma A; Zhang L; Wang X; Chen H
    Curr Drug Saf; 2009 May; 4(2):155-66. PubMed ID: 19442109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-cell costimulatory pathways in allograft rejection and tolerance.
    Rothstein DM; Sayegh MH
    Immunol Rev; 2003 Dec; 196():85-108. PubMed ID: 14617200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell costimulatory blockade: new therapies for transplant rejection.
    Gudmundsdottir H; Turka LA
    J Am Soc Nephrol; 1999 Jun; 10(6):1356-65. PubMed ID: 10361876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Costimulation blockade: current perspectives and implications for therapy.
    Kinnear G; Jones ND; Wood KJ
    Transplantation; 2013 Feb; 95(4):527-35. PubMed ID: 23129000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mosaic of immunosuppressive drugs.
    Masri MA
    Mol Immunol; 2003 Jul; 39(17-18):1073-7. PubMed ID: 12835079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-signals in organ transplantation.
    Durrbach A; Francois H; Jacquet A; Beaudreuil S; Charpentier B
    Curr Opin Organ Transplant; 2010 Aug; 15(4):474-80. PubMed ID: 20631615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of human T-cell activation and expansion of regulatory T cells by pig cells overexpressing PD-ligands.
    Plege A; Borns K; Baars W; Schwinzer R
    Transplantation; 2009 Apr; 87(7):975-82. PubMed ID: 19352115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transplantation tolerance: the concept and its applicability.
    Dong VM; Womer KL; Sayegh MH
    Pediatr Transplant; 1999 Aug; 3(3):181-92. PubMed ID: 10487277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
    Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
    J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Memory T-cell exhaustion and tolerance in transplantation.
    Hartigan CR; Sun H; Ford ML
    Immunol Rev; 2019 Nov; 292(1):225-242. PubMed ID: 31808170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of positive costimulatory molecules in transplantation and tolerance.
    Agarwal A; Newell KA
    Curr Opin Organ Transplant; 2008 Aug; 13(4):366-72. PubMed ID: 18685331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organ transplantation: modulation of T-cell activation pathways initiated by cell surface receptors to suppress graft rejection.
    Weatherly K; Braun MY
    Methods Mol Biol; 2011; 677():419-30. PubMed ID: 20941624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of STAT4 and STAT6 signaling in allograft rejection and CTLA4-Ig-mediated tolerance.
    Zhou P; Szot GL; Guo Z; Kim O; He G; Wang J; Grusby MJ; Newell KA; Thistlethwaite JR; Bluestone JA; Alegre ML
    J Immunol; 2000 Nov; 165(10):5580-7. PubMed ID: 11067913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cell costimulatory pathways in allograft rejection and tolerance.
    Clarkson MR; Sayegh MH
    Transplantation; 2005 Sep; 80(5):555-63. PubMed ID: 16177624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Harnessing the immunotherapeutic potential of T-lymphocyte co-signaling molecules in transplantation.
    Ansari AW; Khan MA; Schmidt RE; Broering DC
    Immunol Lett; 2017 Mar; 183():8-16. PubMed ID: 28119073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anergic T cells generated in vitro suppress rejection response to islet allografts.
    Luo Z; Gotoh M; Grochowiecki T; Tanaka T; Kimura F; Kawashima H; Yagita H; Okumura K; Miyasaka M
    Transplantation; 2000 May; 69(10):2144-8. PubMed ID: 10852614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.